Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial of Cardiac Denervation for Reducing the Risk of Atrial Fibrillation After Aortic Arch Replacement

NCT06927908 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.

NCT NCT06927908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06927908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial of Cardiac Denervation for Reducing the Risk of Atrial Fibrillation After Aortic Arch Replacement
Lead sponsor
Beijing Anzhen Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
April 22, 2025
Completion date
January 1, 2027
Enrollment
570 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

aortic arch replacement, atrial fibrillation (af)